FindTrial
Sign In

CYTOLOGY OF SKIN LESIONS

CLINICAL AND CYTOHISTOPATHOLOGICAL STUDY OF SKIN LESIONS WITH SPECIAL REFERENCE TO BULLOUS, INFECTIOUS AND NEOPLASTIC SKIN LESIONS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/11/004156
Enrollment
30
Registered
2013-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- bullous, infectious and neoplastic skin lesions

Interventions

Control Intervention1: histopatholgy: biopsy sections. Control Intervention2: cytology: skin scraping, slit smears ,fine needle aspiration and tzank smears

Sponsors

MENDONCA BRYNE SHAREL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: clinical suspicion of leprosy,leishmaniasis,cutaneous neoplasms,secondaries and vesiculobullous lesions

Exclusion criteria

Exclusion criteria: patients not willing for the cytological study and cases with inadequate cytological material

Design outcomes

Primary

MeasureTime frame
1. To find out the utility of cytology as the first line investigation in evaluating skin lesions. 2. To correlate clinical, cytological and histopathological findings of various skin lesions. Timepoint: 3 years and six months—

Secondary

MeasureTime frame
cytology as a diagnostic toolTimepoint: 3 years and six months—

Countries

India

Contacts

Public ContactMENDONCA BRYNE SHAREL

FATHER MULLER MEDICAL COLLEGE

hilda67@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026